American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma

Authors:

Abstract
No abstract available
Funding Information
  • Office of Naval Research
  • National Heart, Lung, and Blood Institute
  • Celgene
  • National Institutes of Health (P01CA111412, R01AI128775, R01CA152108, R01CA215134, R01CA218285, R01CA231141, R01HL126589, R01HL129472, R01HL130388, R01HL131731, U01AI069197, U01AI126612, UG1HL06924)
  • U.S. Department of War
  • AbbVie
  • CytoSen Therapeutics
  • Boston Children's Hospital
  • Karyopharm Therapeutics
  • U.S. Public Health Service (U24CA076518)
  • Kiadis Pharma
  • Miltenyi Biotec
  • Amgen
  • Sanofi
  • National Cancer Institute
  • Leukemia and Lymphoma Society
  • National Institute of Allergy and Infectious Diseases (HHSH250201700006C, OT3HL147741, U01HL128568, U24HL138660)
  • Health Resources and Services Administration (N00014-20-1-2705, N00014-20-1-2832)
  • Genentech Foundation
  • Stanford University
  • Incyte
  • Gilead Sciences
  • Legend Biotech (EcoR1)
  • St. Baldrick's Foundation
  • Daiichi-Sankyo
  • Spectrum Pharmaceuticals
  • Bayer Fund
  • Angiocrine Bioscience
  • GlaxoSmithKline
  • Bristol-Myers Squibb
  • Astellas Pharma US
  • AstraZeneca
  • Genentech
  • Biomedical Advanced Research and Development Authority
  • Merck
  • TG Therapeutics
  • Novartis
  • Kite Pharma
  • Roche
  • Government of South Australia
  • Jazz Pharmaceuticals
  • Takeda Pharmaceuticals U.S.A.
  • CSL Behring
  • Janssen Pharmaceutica
  • U.S. Navy
  • Merck Sharp and Dohme United Kingdom
  • Dana-Farber Cancer Institute

This publication has 35 references indexed in Scilit: